ORGO (Organogenesis Holdings) Float Percentage Of Total Shares Outstanding: 63.58% (As of Jul. 05, 2026)


ORGO Organogenesis Holdings Inc ORGO
67 GF Score
Price $2.36
GF Value $3.10
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Organogenesis Holdings Float Percentage Of Total Shares Outstanding?

Organogenesis Holdings ORGO -3.08% 67 Float Percentage Of Total Shares Outstanding is 63.58% as of Jul. 05, 2026. GuruFocus rates ORGO with a GF Score™ of 67/100 and a GF Value™ of $3.10 (Modestly Undervalued). The stock has 5 warning signs investors should review.

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Organogenesis Holdings's float shares is 81.81 Mil. Organogenesis Holdings's total shares outstanding is 128.67 Mil. Organogenesis Holdings's float percentage of total shares outstanding is 63.58%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Organogenesis Holdings's Insider Ownership is 9.96%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Organogenesis Holdings's Institutional Ownership is 51.86%.

ORGO
67GF Score
Organogenesis Holdings Inc ORGO
Float Percentage Of Total Shares Outstanding is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Organogenesis Holdings Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Organogenesis Holdings's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=81.81/128.67
=63.58%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Float Percentage Of Total Shares Outstanding of 63.58% mean?
Organogenesis Holdings (ORGO) has a Float Percentage Of Total Shares Outstanding of 63.58% as of Jul. 05, 2026. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Organogenesis Holdings and its competitors.
Is Organogenesis Holdings' Float Percentage Of Total Shares Outstanding too high?
Organogenesis Holdings' current Float Percentage Of Total Shares Outstanding is 63.58%. Overall, Organogenesis Holdings has a GF Score™ of 67/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Organogenesis Holdings' Float Percentage Of Total Shares Outstanding compare to TKNO and AKBA?
Organogenesis Holdings' Float Percentage Of Total Shares Outstanding of 63.58% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Float Percentage Of Total Shares Outstanding for a Drug Manufacturers company?
A good Float Percentage Of Total Shares Outstanding depends on the Drug Manufacturers industry context. However, Float Percentage Of Total Shares Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Float Percentage Of Total Shares Outstanding mean?
A high Float Percentage Of Total Shares Outstanding can signal that a stock is expensive relative to its fundamentals. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Organogenesis Holdings and its competitors. Organogenesis Holdings's current Float Percentage Of Total Shares Outstanding is 63.58%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Organogenesis Holdings stock overvalued right now?
Based on GuruFocus' analysis, Organogenesis Holdings (ORGO) is currently considered Modestly Undervalued. The stock's GF Value™ is $3.10, compared to a current price of $2.36 — trading 23.9% below its estimated fair value. The current Float Percentage Of Total Shares Outstanding is 63.58%. Organogenesis Holdings' overall GF Score™ is 67/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Float Percentage Of Total Shares Outstanding calculated?
Float Percentage Of Total Shares Outstanding is calculated from a company's financial statements. For Organogenesis Holdings (ORGO), the current Float Percentage Of Total Shares Outstanding is 63.58% as of Jul. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Organogenesis Holdings (ORGO) Overvalued in 2026?

Based on GuruFocus' analysis, Organogenesis Holdings stock appears to be undervalued. The current stock price of $2.36 is trading 23.9% below its estimated GF Value™ of $3.10. GuruFocus considers Organogenesis Holdings to be Modestly Undervalued.

Key valuation signals for ORGO:

  • Float Percentage Of Total Shares Outstanding: 63.58%
  • GF Value™: $3.10 vs. price of $2.36 (23.9% below fair value)
  • GF Score™: 67/100 with 5 warning signs

No single metric tells the full story. See the ORGO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Organogenesis Holdings Business Description

Other Exchanges 2PQ:Germany
Address 85 Dan Road, Canton, MA, USA, 02021
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.
67GF Score

Get the complete analysis for ORGO

Float Percentage Of Total Shares Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.36
Price
$3.10
GF Value